Form D · Other
Bright Peak Therapeutics, Inc.
Del Mar, CA · CIK 0001813343
Offering snapshot reported Jun 11, 2024 · SEC filing
- Reported sold
- $90M Offering amount: $90M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 7, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 11, 2024 | Initial | $89,999,991 | No comparison | 21 | SEC filing |
| Jun 11, 2021 | Initial | $106,500,011 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-515688
Source: Form D, filed Jun 11, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jacob Chacko | Director |
| Leena Gandhi | Director |
| Bertolt Kreft | Executive |
| Alexander Mayweg | Director |
| Emily Minkow | Director |
| Vijaya Pattabiraman | Executive |
| Josh Resnick | Director |
| Matthew Robbins | Executive |
| Michael Rosenzweig | Director |
| Laura Shawver | Director |
| Christine Siu | Director |
| Jon Wigginton | Executive |
| Fredrik Wiklund | Director, Executive |
| Tom Woiwode | Director |
| Asish Xavier | Director |
Issuer details
Industry: Other (See others in industry)
Address:
2010 Jimmy Durante Blvd Suite 150
Del Mar, CA, 92014
Del Mar, CA, 92014